Inbody Coltd Stock Working Capital
| 041830 Stock | KRW 21,300 500.00 2.29% |
InBody CoLtd fundamentals help investors to digest information that contributes to InBody CoLtd's financial success or failures. It also enables traders to predict the movement of InBody Stock. The fundamental analysis module provides a way to measure InBody CoLtd's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InBody CoLtd stock.
InBody |
InBody CoLtd Company Working Capital Analysis
InBody CoLtd's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current InBody CoLtd Working Capital | 53.19 B |
Most of InBody CoLtd's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InBody CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, InBody CoLtd has a Working Capital of 53.19 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The working capital for all Republic of Korea stocks is notably lower than that of the firm.
InBody Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InBody CoLtd's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InBody CoLtd could also be used in its relative valuation, which is a method of valuing InBody CoLtd by comparing valuation metrics of similar companies.InBody CoLtd is rated third in working capital category among its peers.
InBody Fundamentals
| Return On Equity | 18.84 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 331.29 B | |||
| Shares Outstanding | 13.48 M | |||
| Shares Owned By Insiders | 28.69 % | |||
| Shares Owned By Institutions | 19.22 % | |||
| Price To Earning | 30.89 X | |||
| Price To Sales | 2.02 X | |||
| Revenue | 137.84 B | |||
| Gross Profit | 77.06 B | |||
| EBITDA | 37.57 B | |||
| Net Income | 33.98 B | |||
| Cash And Equivalents | 18.56 B | |||
| Total Debt | 1.83 B | |||
| Current Ratio | 4.60 X | |||
| Cash Flow From Operations | 30.35 B | |||
| Target Price | 33000.0 | |||
| Number Of Employees | 222 | |||
| Beta | 1.01 | |||
| Market Capitalization | 326.28 B | |||
| Total Asset | 203.76 B | |||
| Retained Earnings | 73.14 B | |||
| Working Capital | 53.19 B | |||
| Current Asset | 64.45 B | |||
| Current Liabilities | 11.26 B | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 203.76 B |
About InBody CoLtd Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InBody CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InBody CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InBody CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with InBody CoLtd
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InBody CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InBody CoLtd will appreciate offsetting losses from the drop in the long position's value.Moving together with InBody Stock
Moving against InBody Stock
| 0.66 | 003535 | Hanwha InvestmentSecuri | PairCorr |
| 0.61 | 122870 | YG Entertainment | PairCorr |
| 0.58 | 032640 | LG Uplus | PairCorr |
| 0.53 | 011390 | Busan Industrial | PairCorr |
| 0.5 | 041510 | SM Entertainment | PairCorr |
The ability to find closely correlated positions to InBody CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InBody CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InBody CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InBody CoLtd to buy it.
The correlation of InBody CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InBody CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InBody CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InBody CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in InBody Stock
InBody CoLtd financial ratios help investors to determine whether InBody Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InBody with respect to the benefits of owning InBody CoLtd security.